On ECHEMI
Home > Drugs > Mizoribine Registered Holders
Mizoribine structure

Mizoribine structure

Mizoribine

Mizoribine(NSC 289637; HE 69; β-Bredinin) is an immunosuppressive agents (IC50=100 uM) that inhibit the proliferation of lymphocytes selectively, via inhibition of IMPDH.IC50 Value:Target: IMPDHin vitro: Unlike azathioprine, Mizoribine is not taken up by nucleic acids in the cell. Instead, after phosphorylation MZR-5 -monophosphate inhibits GMP synthesis by the antagonistic blocking of IMPDH (Ki = 10(-8)M) and GMP- synthetase (Ki =10(-5) M) [1]. Pretreatment of cells with MZR partially,

Find 3 Related Holders

PHARMACOSTECH CO.,LTD.
South Korea South Korea

API Registration Country

API Active
  • Country:

    South Korea South Korea
North China Pharmaceutical Huasheng Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    1995-05-04
  • Country:

    China China
  • Address:

    No. 8 Yangzi Road, Shijiazhuang Economic and Technological Development Zone
  • Tax NO.:

    91130182601702614Y
  • Registered Funds:

    237.4751 million yuan
  • Email:

Nanjing Hicin Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2003-01-15
  • Country:

    China China
  • Address:

    No. 1 Hengfa Road, Nanjing Economic and Technological Development Zone
  • Tax NO.:

    913201927453675877
  • Registered Funds:

    120 million yuan
  • Website:

  • Email:

Recommended Suppliers of Mizoribine
View 40 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.